Target Price | ¥8,670.00 |
Price | ¥7,218.00 |
Potential |
20.12%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target Chugai Pharmaceutical 2026 .
The average Chugai Pharmaceutical target price is ¥8,670.00.
This is
20.12%
register free of charge
¥11,340.00
57.11%
register free of charge
¥6,565.00
9.05%
register free of charge
|
|
A rating was issued by 20 analysts: 12 Analysts recommend Chugai Pharmaceutical to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2026 of
20.12%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion ¥ | 1,170.61 | 1,246.12 |
5.33% | 6.45% | |
EBITDA Margin | 46.87% | 51.14% |
16.70% | 9.12% |
18 Analysts have issued a sales forecast Chugai Pharmaceutical 2025 . The average Chugai Pharmaceutical sales estimate is
This results in the following potential growth metrics:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share ¥ | 235.36 | 268.42 |
18.99% | 14.05% | |
P/E | 26.97 |
17 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Chugai Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.